Marksans Pharma Limited today signed a share buy agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubai-based front- marketing and promotion company...
The globally active Eppendorf Group is building a new plant for high-quality laboratory consumables made of functional high-tech polymers. To this end, the Hamburg-based life science company is acquiring a former production site at the location...
Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor), teneligliptin, with pioglitazone...
Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA)...
The world's largest vaccine maker, the Serum Institute of India, has halted production of the locally made version of the AstraZeneca Covid-19 vaccine due to falling demand, its chief executive said Friday. The Serum Institute has produced more than
Pharmaceutical Industry has long been on a journey of exploring channels beyond traditional face-to-face interactions and print media when engaging with healthcare professionals (HCPs).
In a bid to develop the innovation ecosystem in Ayush sector, Federation of Indian Chambers of Commerce & Industry (FICCI) has called for a long-term plan detailing actions needed to create robust education, research, standardization...
Mylo, a platform for expecting and new mothers, has announced a funding round of $17 million led by W Health Ventures, a US-based digital health investor, ITC and Endiya Partners.
An Expert panel of India’s central drug authority has suggested granting emergency use authorisation for Biological E’s COVID-19 vaccine Corbevax for children in the five to 11 years age group with certain conditions, official sources...
Innovative credit products that include funds against Intellectual property rights are being examined by the government with an aim to increase the credit flow to the pharmaceuticals industry.
, CDSCO.jpg)
